Ensuring vaccine safety
- 11 December 2020
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 370 (6522), 1274-1275
- https://doi.org/10.1126/science.abf0357
Abstract
Comprehensive safety testing is based on experience with prior vaccinesThis publication has 12 references indexed in Scilit:
- Effect of Dengue Serostatus on Dengue Vaccine Safety and EfficacyThe New England Journal of Medicine, 2018
- Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of ageVaccine, 2017
- Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent FcγR PathwayJournal of Virology, 2011
- “Prepandemic” Immunization for Novel Influenza Viruses, “Swine Flu” Vaccine, Guillain‐Barré Syndrome, and the Detection of Rare Severe Adverse EventsThe Journal of Infectious Diseases, 2009
- The Cutter Incident, 50 Years LaterThe New England Journal of Medicine, 2005
- The value of vaccination: a global perspectiveVaccine, 2003
- Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus.The Journal of Immunology, 1993
- RNA pattern of ‘Swine’ influenza virus isolated from man is similar to those of other swine influenza virusesNature, 1976
- RESPIRATORY SYNCYTIAL VIRUS DISEASE IN INFANTS DESPITE PRIOR ADMINISTRATION OF ANTIGENIC INACTIVATED VACCINE12American Journal of Epidemiology, 1969